Literature DB >> 12107419

The 2001 Canadian recommendations for the management of hypertension: Part one--Assessment for diagnosis, cardiovascular risk, causes and lifestyle modification.

Kelly B Zarnke1, Finlay A McAlister, Norman R C Campbell, Mitchell Levine, Ernesto L Schiffrin, Steven Grover, Donald W McKay, Martin G Myers, Thomas W Wilson, Simon W Rabkin, Ross D Feldman, Ellen Burgess, Peter Bolli, George Honos, Marcel Lebel, Karen Mann, Carl Abbott, Sheldon Tobe, Robert Petrella, Rhian M Touyz.   

Abstract

OBJECTIVE: To provide updated, evidence-based recommendations for the assessment of the diagnosis, cardiovascular risk, identifiable causes and lifestyle modifications for adults with high blood pressure. OPTIONS: For persons in whom a high blood pressure value is recorded, hypertension is diagnosed based on the appropriate measurement of blood pressure, the level of the blood pressure elevation and the duration of follow-up. In addition, the presence of concomitant vascular risk factors, target organ damage and established atherosclerotic diseases must be assessed to determine the urgency, intensity and type of treatment. For persons receiving a diagnosis of hypertension, defining the overall risk of adverse cardiovascular outcomes requires an assessment of concomitant vascular risk factors, including laboratory testing, a search for target organ damage and an assessment for modifiable causes of hypertension. Home and ambulatory blood pressure assessment and echocardiography are options for selected patients. OUTCOMES: The outcomes were: the identification of persons at increased risk of adverse cardiovascular outcomes; the quantification of overall cardiovascular risk; and the identification of persons with potentially modifiable causes of hypertension. EVIDENCE: Medline searches were conducted from one year before the period of the last revision of the Canadian recommendations for the management of hypertension (May 1999 to May 2001). Reference lists were scanned, experts were polled, and the personal files of the subgroup members and authors were used to identify other studies. Identified articles were reviewed and appraised, using prespecified levels of evidence, by content experts and methodological experts. In addition to an update of the previous year's review, new sections on assessing overall cardiovascular risk and endocrine causes are provided. VALUES: A high value was placed on the identification of persons at increased risk of cardiovascular morbidity and mortality, and of persons with identifiable causes of hypertension. BENEFITS, HARMS AND COSTS: The identification of persons at higher risk of cardiovascular disease will permit counseling for lifestyle manoeuvres and introduction of antihypertensive drugs to reduce blood pressure for patients with sustained hypertension. The identification of specific causes of hypertension may permit the use of cause-specific interventions. In certain subgroups of patients, and for specific classes of drugs, blood pressure lowering has been associated with reduced cardiovascular morbidity or mortality. RECOMMENDATIONS: The present document contains recommendations for the assessment of the diagnosis, cardiovascular risk, identifiable causes and lifestyle modifications for adults with high blood pressure. These include the accurate measurement of blood pressure, criteria for the diagnosis of hypertension and recommendations for follow-up, assessment of overall cardiovascular risk, routine and optional laboratory testing, assessment for renovascular and endocrine causes, home and ambulatory blood pressure monitoring, the role of echocardiography and lifestyle modifications. VALIDATION: All recommendations were graded according to the strength of the evidence and voted on by the Canadian Hypertension Recommendations Working Group. Only those recommendations achieving high levels of consensus are reported. These guidelines will be updated annually. ENDORSEMENT: These guidelines are endorsed by the Canadian Hypertension Society, The Canadian Coalition for High Blood Pressure Prevention and Control, The College of Family Physicians of Canada, The Heart and Stroke Foundation of Canada, The Adult Disease Division and Bureau of Cardio-Respiratory Diseases and Diabetes at the Centre for Chronic Disease Prevention and Control, Health Canada.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12107419

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  8 in total

1.  2001 Canadian hypertension recommendations. What has changed?

Authors: 
Journal:  Can Fam Physician       Date:  2002-10       Impact factor: 3.275

2.  The 2001 Canadian hypertension recommendations: take-home messages.

Authors:  Norman R C Campbell; Denis Drouin; Ross D Feldman
Journal:  CMAJ       Date:  2002-09-17       Impact factor: 8.262

3.  The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I--Blood pressure measurement, diagnosis and assessment of risk.

Authors:  B R Hemmelgarn; Finlay A McAlister; Steven Grover; Martin G Myers; Donald W McKay; Peter Bolli; Carl Abbott; Ernesto L Schiffrin; George Honos; Ellen Burgess; Karen Mann; Thomas Wilson; Brian Penner; Guy Tremblay; Alain Milot; Arun Chockalingam; Rhian M Touyz; Sheldon W Tobe
Journal:  Can J Cardiol       Date:  2006-05-15       Impact factor: 5.223

4.  Missed opportunities for the secondary prevention of cardiovascular disease in Canada.

Authors:  Daniel G Hackam; Lawrence A Leiter; Andrew T Yan; Raymond T Yan; Aurora Mendelsohn; Mary Tan; Louis Zavodni; Richard Chen; Jennifer L Tsang; Anjali Kundi; Peter J Lin; David H Fitchett; Anatoly Langer; Shaun G Goodman
Journal:  Can J Cardiol       Date:  2007-12       Impact factor: 5.223

5.  The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: part 1- blood pressure measurement, diagnosis and assessment of risk.

Authors:  Raj S Padwal; Brenda R Hemmelgarn; Finlay A McAlister; Donald W McKay; Steven Grover; Thomas Wilson; Brian Penner; Ellen Burgess; Peter Bolli; Michael Hill; Jeff Mahon; Martin G Myers; Carl Abbott; Ernest L Schiffrin; George Honos; Karen Mann; Guy Tremblay; Alain Milot; Lyne Cloutier; Arun Chockalingam; Nadia A Khan; Simon W Rabkin; Martin Dawes; Rhian M Touyz; Sheldon W Tobe
Journal:  Can J Cardiol       Date:  2007-05-15       Impact factor: 5.223

6.  A randomized trial of mail vs. telephone invitation to a community-based cardiovascular health awareness program for older family practice patients [ISRCTN61739603].

Authors:  Tina Karwalajtys; Janusz Kaczorowski; Larry W Chambers; Cheryl Levitt; Lisa Dolovich; Bea McDonough; Christopher Patterson; James E Williams
Journal:  BMC Fam Pract       Date:  2005-08-19       Impact factor: 2.497

7.  Renal athersosclerotic revascularization evaluation (RAVE study): study protocol of a randomized trial [NCT00127738].

Authors:  Sheldon W Tobe; M Atri; N Perkins; R Pugash; Chaim M Bell
Journal:  BMC Nephrol       Date:  2007-01-26       Impact factor: 2.388

8.  Acute and chronic impact of dynamic exercise on arterial stiffness in older hypertensives.

Authors:  Kunihiko Aizawa; Robert J Petrella
Journal:  Open Cardiovasc Med J       Date:  2008-02-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.